Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches

Fig. 5

Prognostic role of DEGs modulated by guadecitabine in GBM. Forest plot showed the top 10 genes with the highest positive or negative influence on TCGA GBM patients' OS screened by univariate Cox regression analysis (p-value < 0.05). Each gene is accompanied by a point estimate of its hazard ratio and 95% confidence interval

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us